Johanna Mora

The FALCON program: Two phase 2b randomized, double-blind, placebo-controlled studies to assess the efficacy and safety of pegbelfermin in the treatment of patients with nonalcoholic steatohepatitis and bridging fibrosis or compensated cirrhosis

Manal F. Abdelmalek, Edgar D. Charles, Arun J. Sanyal et al. · Contemporary Clinical Trials · 2021 · 60 citations · Full text

Application of The Gyrolab™ Platform to Ligand-Binding Assays: A User’s Perspective

Johanna Mora, Linda Obenauer-Kutner, Vimal Patel · Bioanalysis · 2010 · 54 citations

Engineering, Analytical Microsystems, Gyrolab Microfluidics Platform +22

Pharmacokinetic, Pharmacodynamic, and Safety Profile of a Novel Anti-CD28 Domain Antibody Antagonist in Healthy Subjects

Rong Shi, Marek Honczarenko, Sean X. Zhang et al. · The Journal of Clinical Pharmacology · 2016 · 43 citations · Full text

Healthy Subjects, Immunology, Pharmacotherapy +20

Comparison of Titer and Signal to Noise (S/N) for Determination of Anti-drug Antibody Magnitude Using Clinical Data from an Industry Consortium

Marta Starcevic Manning, Mohamed Hassanein, Michael A. Partridge et al. · The AAPS Journal · 2022 · 27 citations · Full text

Neutralizing Antibody Validation Testing and Reporting Harmonization

Heather Myler, João Pedras-Vasconcelos, Todd Lester et al. · The AAPS Journal · 2023 · 24 citations · Full text